Gyre Therapeutics (GYRE) EBT Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 148,734.00 |
| Dec 31, 2025 | 90,944.00 |
| Sep 30, 2025 | 182,037.00 |
| Jun 30, 2025 | 104,865.00 |
| Mar 31, 2025 | 4,994.00 |
| Mar 31, 2023 | 8.41 Mn |
| Dec 31, 2022 | 185,301.00 |
| Mar 31, 2022 | -30,379.00 |
| Dec 31, 2021 | 444,935.00 |
| Sep 30, 2021 | 327,998.00 |
| Jun 30, 2021 | 267,573.00 |
| Mar 31, 2021 | 176,706.00 |
| Dec 31, 2020 | 500,734.00 |
| Sep 30, 2020 | 151,835.00 |
| Jun 30, 2020 | -53,552.00 |
| Mar 31, 2020 | 97,271.00 |
| Mar 31, 2018 | -8.38 Mn |
| Dec 31, 2017 | 84,080.00 |
| Sep 30, 2017 | -79,579.00 |
| Jun 30, 2017 | -535,028.00 |
| Mar 31, 2017 | -153,682.00 |
| Dec 31, 2016 | -522,994.00 |
| Sep 30, 2016 | -432,930.00 |
| Jun 30, 2016 | -442,306.00 |
| Mar 31, 2016 | -332,769.00 |
| Dec 31, 2015 | -596,501.00 |
| Sep 30, 2015 | -533,067.00 |
| Jun 30, 2015 | -317,851.00 |